Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2020 | Story Thabo Kessah | Photo Supplied
Siphamandla Shabangu hopes to develop intercontinental networks during the Qatar University webinar.

“Assume you are in a leadership position, what can you do to improve the future of higher education?”
This is one of the questions Qwaqwa Campus SRC member, Siphamandla Shabangu, will be discussing during an international webinar to be hosted by Qatar University on Monday 5 October 2020. He will represent the University of the Free State, South Africa, and the African continent as a panellist to discuss the topic: Preparing for an Unpredictable Future: Global Insights from Higher Education Students. 

“Words to describe how it feels to represent not only my campus or institution, but the whole South African nation can never express this new feeling I have,” said Siphamandla. “I have never been afforded such an auspicious opportunity. This is indeed a new feeling for me, and I will do my best to turn it into a habit. I am honoured to have been selected to represent South Africa in a global academic and leadership space. I am a proud UFS ambassador and hope to one day become the face of the University of the Free State,” he added.

Tough selection process

Siphamandla revealed that the process of selection started with the Career Development office on campus. “I was selected among many greater minds on the Qwaqwa Campus. Fortunately, I further prospered among students across all three campuses of the University of the Free State, and finally became one of the best among the greats. Now, I am proud to be part of six unique panellists from different countries to unpack the impact of COVID-19 on institutions of higher learning. In fact, it is a prestigious honour to be the only African panellist – black African for that matter – in this global panel discussion,” he said.

Looking forward to the webinar

“I would very much like to acquire student lived experiences from countries outside the continent during the COVID-19 pandemic. I am also interested to know what methods of learning are sustainably applied at higher learning institutions from the perspectives of developing and highly developed countries. Moreover, I am eager to find out as to what leadership-inspired methods work best in different continents within the educational space that is gradually consumed by the Fourth Industrial Revolution. Furthermore, I am looking forward to developing international and intercontinental networks that will equip me to best explore opportunities across the globe. The academic space is dominated by intellects, visionaries, hustlers, lifelong learners, problem solvers, and even creative thinkers such as artists. However, it is within us to broaden the potential we have in life. It would be gratifying to know higher education systems from other prominent countries,” said Siphamandla.

The panel discussion will take place on Monday 5 October from 12:00 to13:00 (South African time). Other panellists are from the United Kingdom, Russia, Japan, Turkey, and Qatar. 

Siphamandla is currently serving as the SRC member responsible for Universal Access and Social Justice Council.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept